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Abstract
Study Objectives: Depression is among the most prevalent perinatal complications, yet modifiable risk factors remain elusive. Over half
of perinatal women endorse clinical insomnia symptoms, which are etiologically implicated in depression in nonperinatal samples. Yet,
prospective data on perinatal insomnia and depression are mixed. We sought to clarify temporal associations of insomnia and depression
during peripartum, and to investigate cognitive arousal as a potential mechanism facilitating this relationship.
Methods: Seventy pregnant women completed sociodemographic information and baseline sleep and mood symptoms between gestational
weeks 25 and 30. Beginning at gestational week 30, participants completed 17 weekly online surveys assessing insomnia, depression, and
three cognitive arousal indices (nocturnal cognitive arousal, perseverative thinking, and perinatal-focused rumination). Mixed effects models
were conducted to test hypotheses.
Results: Women were at risk for depression when experiencing insomnia (odds ratio [OR] = 2.36, 95% confidence interval [CI] = 1.28 to 4.35),
nocturnal cognitive arousal (OR = 3.05, 95% CI = 1.60 to 5.79), perinatal-focused rumination (OR = 2.05, 95% CI = 1.11 to 3.79), and perseverative
thinking (OR = 7.48, 95% CI = 3.90 to 14.32). Prospective analyses revealed bidirectional effects between insomnia and cognitive arousal, and
both predicted future depression. Nocturnal cognitive arousal mediated 23–43% of the effect of insomnia on depression. Insomnia mediated
12%–18% of the effect of nocturnal cognitive arousal on depression. A similar pattern was observed with perinatal-focused rumination.
Depression did not predict insomnia.
Conclusion: Nocturnal cognitive arousal, including ruminating on perinatal concerns while trying to fall asleep, fuels insomnia. In turn, lying
awake at night provides an opportunity for nocturnal cognitive arousal. This cycle feeds perinatal depression. Daytime cognitive arousal may
indirectly disrupt sleep as perseverating during the day persists into the night.

Statement of Significance
Depression is a serious perinatal complication. In nonperinatal samples, insomnia and cognitive arousal are implicated in depression etiology, yet their
temporal associations with perinatal depression are poorly characterized. We collected health reports from 70 women across late pregnancy and early
postpartum. We observed a toxic cycle between insomnia and cognitive arousal wherein cognitive arousal at night produced insomnia, and insomnia
provided an opportunity for cognitive arousal at night. This cycle fueled perinatal depression. Critically, depression risk was highest when women experienced insomnia and high cognitive arousal at the same time. Depression fed into cognitive arousal, but did not directly impact sleep. Our results
suggest that insomnia and cognitive arousal are key therapeutic targets for the prevention and maximal treatment of perinatal depression.
Key words: worry; pregnancy; postpartum; sleep; prospective; cognitive–emotional; hyperarousal

Submitted: 27 August, 2020; Revised: 1 January, 2021
Published by Oxford University Press on behalf of Sleep Research Society (SRS) 2021.
This work is written by (a) US Government employee(s) and is in the public domain in the US.

1

Downloaded from https://academic.oup.com/sleep/advance-article/doi/10.1093/sleep/zsab028/6217388 by Henry Ford Hospital - Sladen Library user on 25 May 2021

Original Article

2

|

SLEEPJ, 2021, Vol. XX, No. XX

Introduction
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Perinatal depression refers to major and minor depression that
occurs in pregnancy and/or the first postpartum year. Estimates
suggest that 10%–19% of women experience major or minor depression at some point during pregnancy and postpartum [1–3],
thereby supporting depression as one of the most highly prevalent perinatal complications. Perinatal depression is a serious
and debilitating condition that affects both mother and child.
Depressed mothers are more likely to have suicidal thoughts and
struggle with caregiving, resulting in fewer well-child visits and
vaccinations, more infant sleep problems, and poorer adherence
to safety practices [4, 5]. To help detect women at risk for perinatal depression, researchers have identified factors influencing
depressive symptoms during pregnancy and postpartum. Some
factors are perinatal-specific, such as prior prenatal loss [6],
pregnancy-related anxiety [7], and concerns about fetal health
[8]. Other etiological factors have been firmly established first in
the broader depression literature, such as genetics [9] and cognitive arousal, particularly in the form of perseverative/repetitive
thinking [10]. In the broader depression population, insomnia
precedes half of all incident and relapse depression cases [11].
And yet, despite evidence characterizing insomnia as a robust
risk factor for depression [12], the role of insomnia in perinatal
depression remains poorly characterized.
Perinatal insomnia is a public health crisis. Over half of pregnant women meet diagnostic criteria for insomnia disorder or
screen positive for clinically significant insomnia symptoms
[13, 14]. Despite this high prevalence, perinatal insomnia is not
typically assessed in routine obstetric evaluation. Historically,
sleep disturbance has been considered a normative experience
in pregnancy, dismissed by healthcare providers as unworthy of
attention beyond reassurance [15]. However, insomnia during
pregnancy is often not merely a transient disruption in sleep,
and women with clinically significant insomnia in early pregnancy consistently report disturbed sleep throughout pregnancy
[16]. Importantly, insomnia symptoms frequently persist long
after delivery [14]. The course of perinatal insomnia appears
chronic as half of all postpartum women complain of symptoms
2 years after childbirth [17], and many do not recover fully until
6 years postpartum [18]. Given the high rates of insomnia and
depression in pregnancy and postpartum, coupled with robust
literature supporting insomnia as a risk factor for depression in
the general population, the role of insomnia in perinatal depression development has received considerable attention.
Depression rates are estimated at 19%–26% in pregnant and
postpartum women with insomnia compared to just 4% among
perinatal women without insomnia [5, 14, 19]. Despite strong
support for an association between insomnia and depression
in peripartum [20], prospective data regarding the influence of
insomnia on depressive symptoms have yielded contradictory
findings. Some studies offer support for insomnia as a risk factor
for postpartum depression. In a sample of 142 perinatal women,
Sedov and Tomfohr-Madsen [16] recently showed clinical insomnia in early pregnancy augured a chronic insomnia course
and greater depression levels in early postpartum. Notably,
42% of pregnant women with clinical insomnia developed
postpartum depression compared to just 8% of those without
insomnia symptoms in pregnancy. In a prospective study of 382
women, Marques et al. [21] showed that insomnia in late pregnancy predicts postpartum depressive symptoms. In two other
studies, Okun et al. [22] and Dorheim et al. [23] showed that

sleep disturbances and insomnia symptoms in late pregnancy
predicted postpartum depression, but only in women with histories of depression.
On the other hand, several findings suggest that insomnia
may not exert a direct influence on perinatal depression. In
Dorheim et al.’s [23] aforementioned population study, insomnia in late pregnancy predicted postpartum depression in
women with histories of depression, but not in women who
had never been depressed. In another population-based study,
insomnia during middle pregnancy was associated with concurrent depression, but did not predict postpartum depression
[24]. Another study published by Okun’s team [25] showed that
sleep complaints in late pregnancy did not increase the risk for
postpartum depression, but rather predicted the timing of depression onset (a later onset, rather than earlier, curiously). In
Marques et al.’s aforementioned study, the prospective association of prenatal insomnia and postpartum depression became nonsignificant when controlling for negative and positive
mood ratings. The authors proposed that insomnia may influence perinatal depression via an indirect path involving cognitive–emotional regulation. Overall, prospective studies provide
modest and inconsistent evidence that insomnia may increase
symptoms of perinatal depression.
If perinatal insomnia does predict depression, the extent to
which perinatal insomnia affects depression directly and indirectly via an influence on cognitive–emotional regulation is
unknown. Cognitive arousal, particularly regarding negative
perseverative thought, is an aspect of cognitive–emotional regulation that is especially germane to insomnia and depression [26–
28]. Epidemiological data show that insomnia directly increases
the risk for incident depression [12, 29], but also increases depression risk via cognitive arousal [30, 31]. This insomnia → cognitive
arousal → depression pathway may explain why Marques et al.
[21] found that insomnia’s effect on depression diminished when
accounting for mood; mood disturbances and cognitive arousal
are fundamentally and inextricably linked [32]. Early evidence
suggests that cognitive arousal is strongly associated with insomnia and depression during pregnancy and postpartum.
Most pregnant women, irrespective of insomnia or depression status, endorse high levels of cognitive arousal; levels
commensurate with those observed in individuals with mental
illness [5]. Importantly, many pregnant women report concerns
relating to pregnancy, childbirth, and motherhood, and focusing
on these concerns is linked to maternal depression [7, 33]. As
a result, the manner in which ruminating on perinatal concerns may influence maternal sleep and mental well-being has
drawn recent attention. Unsurprisingly, perinatal women with
insomnia report higher levels of both broadly focused nocturnal
cognitive arousal and perinatal-focused rumination (PFR) than
their good-sleeping counterparts [5, 34].
Although insomnia and cognitive arousal are both highly elevated and closely related in peripartum, they share independent
associations with perinatal depression. Cross-sectional data
offer preliminary support that they may work together to fuel
depression. In an analysis of 257 pregnant women, the highest
depression rates were observed among women with insomnia
and high cognitive arousal (36%) as compared to those with only
insomnia (4%), only high cognitive arousal (11%), or neither (1%)
[5]. The same study showed similar patterns when examining
the combined effects of insomnia and PFR. These cross-sectional
findings are consistent with prospective epidemiological data
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Study Goal 1: Determine prospective effects of
insomnia and cognitive arousal indices on perinatal
depression
Hypothesis: We predicted that insomnia, nocturnal cognitive
arousal, PFR, and perseverative thinking would independently
predict future depressive symptoms.

Study Goal 2: Test mediation models characterizing
the effects of insomnia and cognitive arousal on
depression
Prior studies in the broader insomnia population show that insomnia increases cognitive arousal [31, 37] and that cognitive
arousal increases insomnia [38–41]. Given that insomnia and
cognitive arousal each predict future depression, we hypothesized the following mediation models. Hypothesis 1: We predicted that insomnia would lead to depression, but that this
would be partly mediated by cognitive arousal (Figure 1, Panel
A). Hypothesis 2: We predicted that cognitive arousal would lead
to depression, but that this effect would also be partly mediated
by insomnia (Figure 1, Panel B).

Study Goal 3: Examine whether insomnia and high
cognitive arousal have compounding effects on odds
for depression
Hypothesis: We predicted that depression risk would be highest
when women experienced high levels of insomnia and cognitive
arousal at the same time, relative to when experiencing only insomnia, only high cognitive arousal, or neither. This hypothesis
was based on prior data showing that the combination of insomnia and high cognitive arousal is more depressogenic than
experiencing one without the other [5, 35].

Methods
Study setting and design
The study was approved by the Internal Review Board at the
Henry Ford Health System. Pregnant women receiving care in a
multi-hospital health system centrally located in Metropolitan
Detroit, Michigan, USA were invited to participate in an observational study on perinatal sleep and health. Once enrolled,
participants were asked to complete 17 weekly online surveys
(approximately 15–20 min, hosted by Qualtrics) beginning at
gestational week 30. All participants received routine sleep hygiene tips via email (note: tips were not tailored to pregnancy or
postpartum, but rather were broadly focused on caffeine, light,
electronic devices, etc.). Although childbirth is typically estimated to occur at gestational week 40, the actual timing of delivery varies considerably. Even so, this data collection schedule
was designed to collect health information across most of
the third trimester of pregnancy and approximately the first
1.5 months of postpartum.

Study population
The inclusion criterion for the present study was gestational
age between 25 and 30 weeks at the time of eligibility screening.
Exclusion criteria included high-risk pregnancy per self-report
(e.g. preeclampsia diagnosis, age >40 years), being in the care
of the maternal-fetal medicine team for high-risk pregnancy
(any reason) per electronic medical records, multiple pregnancy,
use of prescription or over-the-counter sleep aids or any other
sedating medications at the time of screening, alcohol or recreational drug use at the time of screening, rotating and/or night
shift work, epilepsy or seizures, bipolar disorder, diagnosis of a
sleep disorder that is untreated (other than insomnia), and severe depression (see the Measures section).
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showing that adults with insomnia and high cognitive arousal
have a higher risk for 2-year incident depression (13%) than
those with only insomnia (4%), only high cognitive arousal (8%),
or neither (3%) [35]. These findings, combined with prospective
data from perinatal and nonperinatal insomnia samples [21, 30,
31], suggest that cognitive arousal may link insomnia to depression in peripartum. However, no studies to date have examined
prospective associations among insomnia, cognitive arousal,
and depression in pregnant or postpartum women.
Prior prospective studies of perinatal insomnia and depression have been methodologically limited in a critical way: They
have focused exclusively on the effects of prenatal insomnia on
postpartum depression. This limited scope is problematic for
two reasons: First, although insomnia symptoms remain highly
prevalent after childbirth, sleep symptoms and challenges drastically change from pregnancy to early postpartum (e.g. greater
sleep deprivation, more external wake-promoting stimuli such
as poor infant sleep and nighttime feedings) [17, 18, 23]. Notably,
insomnia symptoms, while persistent, tend to trend downward
in early postpartum [16], perhaps at least partly due to reduced
sleep opportunity related to nighttime infant caretaking, thus
further complicating the perinatal insomnia–depression relationship. Second, the postpartum period is simply not a robust
trigger for depression development. A review of large perinatal
population studies shows that depression rates are similar between pregnancy and postpartum [3]. Some population studies
show that depression is actually lower in postpartum than in
pregnancy [1, 36]. Therefore, studies testing only for effects of
prenatal insomnia on postpartum depression fail to account for
sleep changes after childbirth and miss critical prenatal changes
in depressive symptoms, thereby diminishing the ability to detect effects of perinatal insomnia on depression. Prospective
studies of insomnia and depression should test temporal associations within pregnancy and postpartum, while accounting for
any potential effects of childbirth on symptom changes.
In the present study, we investigated whether insomnia and
cognitive arousal predict future depression across late pregnancy
and early postpartum. To accomplish this goal, we assessed depressive symptoms, insomnia symptoms, and three cognitive
arousal indices (nocturnal cognitive arousal, nocturnal PFR, and
broadly focused perseverative thinking) for 17 consecutive weeks
across late pregnancy and early postpartum. In this report, the
term “cognitive arousal” in reference to study outcomes applies
to all three measures. Yet, different indices can elucidate the importance of the timing of cognitive arousal symptoms (e.g. night)
and the cognitive content on which perinatal women perseverate
(e.g. perinatal concerns). Our study differed from prior investigations in two critical ways: (1) We examined temporal associations
during pregnancy and postpartum at the same time, rather
than restrict analyses to testing effects of prenatal sleep on
postpartum depression. (2) We accounted for cognitive arousal,
which perinatal women endorse at pathological levels [5], and
have been posited to mediate effects of insomnia on depression
in perinatal and nonperinatal populations [21, 30, 31].
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This study was part of a larger parent study on perinatal
health wherein some participants were randomized to treatment and some were randomized to naturalistic observation.
This study included eligible participants who were randomized
to observation. Invitations advertising a study on perinatal sleep
(without mentioning that we were focused on poor sleep as we
were recruiting good sleepers and those with insomnia) were
sent via email and phone calls to 3,585 patients. A total of 535
women contacted us with interest in our study. Of these patients, 272 women consented to participate in the study, 267 of
whom provided sufficient data for full eligibility determination,
which were collected between September 12, 2018 and March 9,
2019. A total of 70 participants (44 with clinical insomnia and
26 without insomnia) were randomized into this observational
study. All participants provided written informed consent.

Measures
Baseline data
Baseline data were collected during eligibility screening between
gestational weeks 25 and 30. Sociodemographic information included age, annual household income, race, prior birth history,
and history of miscarriages. In addition, we assessed current
medication use, body mass index (derived from electronic medical records), snoring (“Do you snore?” Yes/No), and sleep duration (“During the past month, how many hours of sleep did you
get at night?” from the Pittsburgh Sleep Quality Index) [42].
Depressive symptoms were measured using the Edinburgh
Postnatal Depression Scale (EPDS) [43], a 10-item self-report
measure of depressive symptoms. EPDS scores range from 0 to
30, with higher scores indicating greater severity. A cut-point
of EPDS of at least 10 favors sensitivity over specificity to detect both minor and major depression and is commonly used in
clinical practice to initiate treatment for perinatal depression.
Women who scored at least 18 at baseline were excluded for
severe depression.
Insomnia symptoms were measured using the Insomnia
Severity Index (ISI) [44, 45]. Scores range from 0 to 28 with
higher scores indicating greater severity. ISI of at least 10 indicates clinically significant insomnia symptoms in community

samples [45]. Prior research supports this cutoff for pregnant
women as those who score at least 10 on the ISI report elevated levels of depression, cognitive arousal, and risk for suicidal ideation [5].
The first aspect of cognitive arousal measured was nocturnal
cognitive arousal, which was measured using the Presleep Arousal
Scale—Cognitive factor (PSASC) [46]. Specifically, the PSASC
measures trait tendency for cognitive arousal while trying to fall
asleep at night. Example items from the PSASC are “review or
ponder events of the day” and “can’t shut off thoughts.” Scores
range from 8 to 40 with higher scores indicating greater nocturnal cognitive arousal. PSASC scores of at least 20 represent
high nocturnal cognitive arousal and suggest clinically significant sleep and mood pathology [47].
The second aspect of cognitive arousal measured was nocturnal PFR, which was measured using a single item that we
appended to the PSASC. Specifically, participants were asked
how intensely they “worried or had stressful thoughts about
your pregnancy or new infant” when attempting to fall asleep.
Women who scored 1 (not at all) or 2 (slightly) were considered
low on PFR, whereas women who scored 3 (moderately) through
5 (extremely) were considered high on PFR (notably, the median
was 2).
Repeated measures
Repeated measures were collected weekly starting at gestational
week 30 and for 17 consecutive weeks thereafter. All measures
were modified to assess symptoms over “the prior week” for two
reasons: (1) ensure that assessment windows are consistent
with our weekly repeated measures study design and (2) depression was our primary outcome and the EPDS, our depression
measure, is validated for a 1-week assessment window. Most
repeated measures were included in the baseline assessment.
The EPDS assessed weekly depression symptoms (unchanged
assessment window). The ISI assessed weekly insomnia symptoms (typically measures 2 weeks of symptoms). The PSASC and
the added PFR item assessed nocturnal cognitive arousal and
nocturnal PFR, respectively (originally, the PSASC measures trait
tendencies). The third aspect of cognitive arousal that we measured was perseverative thinking, which was measured using the
Perseverative Thinking Questionnaire (PTQ) which is a 15-item
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Figure 1. Panel A: Hypothesized model wherein cognitive arousal mediates the effect of insomnia on future depression. Panel B: Hypothesized model wherein insomnia mediates the effect of cognitive arousal on future depression. Narratives are included to demonstrate how these processes may work in the real world.
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Analysis plan
Descriptive analyses and baseline group comparisons were
run using SPSS 25. Linear and logit mixed effects models were
run using STATA/SE 15.1. PRODCLIN estimates were performed
using R 4.0.2 and the RMediation package. Descriptive data
analysis involved presenting frequency rates of dichotomous
variables (snoring, obesity, positive insomnia status, etc.) and
means and standard deviations for continuous variables. As
this project primarily focused on the prospective effects of insomnia and high cognitive arousal, we compared women with
insomnia versus without insomnia, and with high versus low
nocturnal cognitive arousal, on sociodemographic characteristics and baseline sleep and mood symptoms. These analyses
were performed to provide an impression of how these groups
differ in late pregnancy.
Our primary study outcome was weekly reports of depressive symptoms in the third trimester of pregnancy and early
postpartum. To account for the time-nested structure of the
outcome variable, we used linear mixed modeling (also known
as hierarchical linear modeling) when estimating depression as
a repeated measures continuous outcome, and mixed effects
logit modeling when estimating depression as a repeated measures binary outcome. This approach permits the examination of
both covariance and lagged effects that may exist between independent variables (IVs) and dependent variables (DVs), revealing
both concurrent and temporal associations. Mixed effects models
allow the time-nested DV to be regressed onto interindividual
factors (variables that represent differences between participants,
which are baseline differences between participants in the present study) and intraindividual factors (variables that represent
changes within participants; fluctuations in symptoms as observed
across repeated measures). Importantly, mixed effects modeling
is robust to the presence of missing data, which are common in
longitudinal studies [49].
For our mixed effects models, we regressed the DV (measured repeatedly, thus an intraindividual factor) on baseline IVs
(measured once, thus an interindividual factor) and repeatedly measured IVs (intraindividual factors). Due to the study
design, results from these models as described here demonstrate (1) prospective effects of baseline factors on depression (i.e. baseline factors predicting differences in depression
levels across peripartum between participants) and (2) concurrent associations between weekly depression scores and other
weekly factors (i.e. weekly symptoms associate with weekly

changes in depression). To test temporal associations among
intraindividual factors (repeated measures), we lagged the repeatedly measured IVs (i.e. lagged refers to intraindividual factors only). Lagged models show temporal associations between
intraindividual IVs and DVs (e.g. does insomnia this week predict depression a week later?). All lagged models control for the
previous week’s value of the DV. For more details and example
equations demonstrating our covariance and lagged effects
mixed models, please refer to Supplementary Materials.
Mediation models were first tested with three primary linear
mixed models. The direct effect (also known as the tau (τ) path)
refers to the IV → DV effect. As mediation analyses must demonstrate directionality ideally utilizing assessments across at least
three time points, we regressed the DV onto the IV lagged by 2
weeks (IVit−2). Next, we tested the indirect effect, which comprises
the alpha (α) path (IV → M) and the beta (β) path (M → DV). For
the α path, we regressed the mediator onto the IV lagged by 1
week (IVit−1). For the β path, we regressed the DV onto the mediator lagged by 1 week (Mit−1), while controlling for the IV lagged
by 2 weeks (IVit−2; i.e. the τ′ path, which is the new estimate of the
direct effect after controlling for the effects of the proposed mediator). Ultimately, our mediation models evaluated IVit−2 → Mit−1
→ DVit, while controlling for appropriate covariates (see Figure 1
at the end of Introduction for hypothesized models).
From these regression models, the product of the α and β
parameter estimates represented the indirect (i.e. mediated)
effect. The confidence intervals (CIs) of the mediated effects
were estimated using the PRODCLIN method in R 4.0.2 using the
RMediation library [50]. This method does not assume a normal
distribution, yields asymmetric CIs, and is more accurate than
traditional significance tests. If the 95% CI for the indirect effect
does not include zero, then significant mediation is inferred.
Proportions of the unadjusted direct effect (τ) accounted for by
the indirect effect (αβ) can be estimated in two simple ways: (1)
αβ/τ and (2) (τ − τ′)/t.

Results
Sample characteristics, baseline clinical symptoms,
and depression rates
Participant ages ranged from 20 to 39 years. Most participants
self-identified racially as non-Hispanic white (57.1%) or nonHispanic black (24.3%). Twenty-six women (37.1%) screened positive for minor or major depression at baseline. Forty-one women
(58.6%) screened positive for depression at least once over the
following 17 weekly assessments (23 of 26 participants who
screened positive at baseline, plus 18 of 44 participants who initially screened negative at baseline). As this project focused on
the effects of insomnia and cognitive arousal, we compared participants by baseline insomnia status and by nocturnal cognitive
arousal status on demographic and baseline symptoms for descriptive purposes. See Table 1 for details on sociodemographics
and group comparisons.

Predicting perinatal depression symptoms:
Identifying clinical signs
A null linear mixed model regressing depression on an intercept
yielded 1,133 observations, indicating the mean number of completed assessments was 16.19 per participant, reflecting a 4.8%
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transdiagnostic measure of repetitive thinking [48]. The PTQ
was not administered at baseline, but was administered weekly.
The valence of many PTQ items is neutral (e.g. My thoughts repeat themselves and Thoughts just pop into my mind), although the
valence of some items is negative (e.g. I think about many problems without solving them). Higher scores on the PTQ indicate a
greater tendency to engage in transdiagnostic, broadly focused
repetitive thinking. Notably, the PTQ is content-independent. In
other words, it does not measure perseverative thinking specific
to depression, anxiety, insomnia, and so on. We are not aware of
any empirically validated PTQ scores to indicate high levels of
repetitive thinking, particularly when assessing over the prior
week. Even so, we operationalized PTQ scores of at least 10 as
high perseverative thinking as it represented levels above the
grand mean for this sample (M ± SD: 9.77 ± 11.04), which identified 35.31% PTQ observations as high (399/1,130).
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Table 1. Sample demographics and characteristics for all patients and by insomnia status at study entry screening
ISI ≥10

ISI <10

70
29.21 ± 4.09 y
27.83 ± .96
12/68; 17.1%
10/67; 14.9%
58/70; 58.6%
12/70; 17.1%
2/70; 2.9%

44
29.14 ± 4.15
27.61 ± .97
8/43; 18.6%
3/41; 7.3%
29/44; 65.9%
9/44; 20.5%
1/44; 2.3%

26
29.35 ± 4.07
28.19 ± .85
4/25; 16.0%
7/26; 26.9%
12/26; 46.2%
3/26; 11.5%
1/26; 3.8%

40; 57.1%
17; 24.3%
3; 4.3%
2; 2.9%
4; 5.7%
4; 5.7%

23; 52.3%
13; 29.5%
3; 6.8%
2; 4.5%
1; 2.3%
2; 4.5%

17; 65.4%
4; 15.4%
0; 0.0%
0; 0.0%
3; 11.5%
2; 7.7%

11.01 ± 5.12
44/70; 62.9%
6.72 ± 1.16
21/70; 30.0%
7.84 ± 4.83
26/70; 37.1%
20.39 ± 7.07
33/70; 47.1%
2.24 ± 1.00
26/70; 37.1%

14.11 ± 3.39
—
6.31 ± 1.19
21/44; 47.7%
9.45 ± 4.67
21/44; 47.7%
22.70 ± 7.10
39/44; 88.6%
2.45 ± 1.04
21/44; 47.7%

5.77 ± 2.66
—
7.42 ± .66
0/26; 0.0%
5.12 ± 3.81
5/26; 19.2%
16.46 ± 5.08
16/26; 61.5%
1.88 ± .82
5/26; 19.2%

t(68) = −0.21, p = 0.838
t(68) = −2.52, p = 0.014
χ 2 = 0.07, p = 0.786
χ 2 = 4.82, p = 0.028
χ 2 = 2.62, p = 0.105
χ 2 = 0.92, p = 0.339
—

t(68) = 10.74, p < 0.001
—
t(67) = -4.49, p < 0.001
χ 2 = 17.73, p < 0.001
t(68) = 4.01, p < 0.001
χ 2 = 5.68, p = 0.017
t(68) = 3.93, p < 0.001
χ 2 = 7.13, p = 0.008
t(68) = 2.38, p = 0.020
χ2=5.68, p=.017

PSASC ≥20

PSASC <20

33
28.85 ± 4.49
27.85 ± .94
9/32; 28.1%
4/31; 12.9%
23/33; 69.7%
5/33; 15.2%
2/36; 6.1%

37
29.54 ± 3.73
27.81 ± 1.00
3/36; 8.3%
6/36; 16.7%
18/37; 48.6%
7/37; 18.9%
0/37; 0.0%

18; 54.5%
10; 30.3%
2; 6.1%
0; 0.0%
3; 9.1%
0; 0.0%

22; 59.5%
7; 18.9%
1; 2.7%
2; 5.4%
1; 2/7%
4; 10.8%

12.58 ± 5.09
18/33; 54.5%
6.52 ± 1.40
14/33; 42.4%
9.85 ± 5.00
18/33; 54.5%
26.24 ± 5.34
—
2.58 ± 1.06
16/33; 48.5%

9.62 ± 4.79
8/37; 21.6%
6.91 ± .86
7/37; 18.9%
6.05 ± 3.93
8/37; 21.6%
15.16 ± 3.30
—
1.95 ± .85
10/37; 27.0%

t(68) = −0.70, p = 0.484
t(68) = 0.16, p = 0.872
χ 2 = 4.57, p = 0.033
χ 2 = 0.19, p = 0.666
χ 2 = 3.19, p = 0.074
χ 2 = 0.17, p = 0.676
—

t(68) = 2.50, p = 0.015
χ 2 = 8.10, p = 0.004
t(68) = −1.42, p = 0.160
χ 2 = 4.59, p = 0.032
t(68) = 3.55, p < 0.001
χ 2 = 8.10, p = 0.004
t(68) = 10.56, p < 0.001
—
t(68) = 2.76, p = 0.008
χ 2 = 3.44, p = 0.064

M ± SD = mean and standard deviation; n; % = number of participants, percentage of sample. Gestational week reflects the status at study entry. Poverty is operationalized as less than $20,000 annual household income. BMI = body mass index before pregnancy, BMI values 35 and higher indicate class II obesity. Snoring indicates whether patients endorsed snoring at study entry baseline.
Antidepressants were reported at baseline, only sertraline was reported. Race was self-reported. ISI = insomnia severity index, a cutoff score represents clinically significant insomnia symptoms
relative to a community sample. Sleep duration represents average nightly sleep over the prior month. Short sleep was operationalized as sleeping 6 h or fewer on average over the past month.
EPDS = Edinburgh Postnatal Depression Scale. EPDS scores 10 and higher suggest probably minor or major depression. PSASC = Presleep Arousal Scale—Cognitive factor. PSASC scores 20 and higher
indicate cognitive hyperarousal. PFR = perinatal-focused rumination, scores of 3 and higher indicate high rumination on perinatal concerns.

missing data rate. An estimated 56% of the variance in depression was due to interindividual differences, whereas 44% was
due to weekly fluctuations within participants.
To test our hypotheses, we used linear mixed effects regression to estimate depressive symptoms as predicted by
sociodemographic factors and baseline depression, insomnia,
nocturnal cognitive arousal, and PFR (interindividual factors),
while controlling for effects of time and changes from pre- to
postpartum (intraindividual factors; Table 2, Model 1). By using
clinical cutoffs, we can identify women in late pregnancy who
may be at risk for perinatal depression. Women who reported
high nocturnal cognitive arousal and PFR were more depressed
across peripartum than women low in cognitive arousal and
rumination. Baseline depression status and snoring, as well as
study week and childbirth, were also associated with depressive
symptoms. Significant predictors in this model were entered as
covariates in subsequent models.
Next, we regressed depression on concurrent insomnia
symptoms, sleep duration, nocturnal cognitive arousal, PFR,
and perseverative thinking (all intraindividual factors), while
controlling for covariates (Table 2, Model 2). Results showed
that women were more depressed when experiencing greater
insomnia, nocturnal cognitive arousal, PFR, and perseverative
thinking. Sleep duration was not independently associated with
depressive symptoms.
To offer more readily interpretable estimates of the magnitude of associations, we ran a posthoc logit mixed effects regression model, which showed that the odds of screening positive for
depression doubled when women reported clinically significant
insomnia (odds ratio [OR] = 2.36) or high PFR at night (OR = 2.05);
see Table 2, Model 3. Odds for positive depression screens were

even greater when women endorsed high nocturnal cognitive
arousal (OR = 3.05) and perseverative thinking (OR = 7.48).

Does nocturnal cognitive arousal mediate the effects
of insomnia on depression?
Next, we conducted a series of linear mixed models to test
whether nocturnal cognitive arousal mediated the effects of insomnia on depression (see Table 3 for full results).
τ path (direct effect)
We first regressed depression on insomnia (lagged by 2 weeks),
while controlling for prior depression and relevant covariates
(Table 3). Results showed that higher levels of insomnia predicted
higher levels of depression 2 weeks later (τ: b = 0.07, p = 0.005). In
other words, we observed a direct effect of insomnia on future
depression. Next, we tested the α path (IV → Mediator) and the β
path (Mediator → DV) of the indirect effect.
α path
Insomnia predicted nocturnal cognitive arousal a week later (α:
b = 0.08, SE = 0.03, p < 0.001; Table 3).
β path
Nocturnal cognitive arousal predicted depression a week later
(β: b = 0.20, SE = 0.02, p < 0.001; Table 3). Notably, insomnia was no
longer a significant predictor in the model (τ′: b = 0.04, p = 0.112).
αβ path (indirect effect)
Using the PRODCLIN method, the αβ path was estimated to be
0.016 (SE = .007, 95% CI = 0.004 to 0.031). Since the CI did not
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Sample size
Age (M ± SD), years
Gestational week (M ± SD)
Poverty (n; %)
BMI ≥35 (n; %)
Multiparous (n; %)
Snoring (n; %)
Antidepressants
Race (n; %)
White
Black
Asian
Middle Eastern or Arabic
Hispanic or Latino
Multiracial
Baseline symptoms
ISI
ISI ≥10
Sleep duration (h)
Short sleep (≤6 h)
EPDS (M ± SD)
EPDS ≥10
PSASC (M ± SD)
PSASC ≥20
PFR (M ± SD)
PFR ≥3

All participants
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Table 2. Identifying insomnia and cognitive arousal factors associated with perinatal depression using linear and logit mixed effects modeling
Model 1, Predicting depression symptoms: Wald χ 2 = 144.25, p < 0.001 (obs = 1,051)
95% CI

z

p

−0.90
−0.03
−1.64
−1.08
2.64
3.81
0.18
0.56
1.51
2.00

−2.76 to 0.96
−0.21 to 0.15
−3.73 to 0.46
−3.27 to 1.11
0.80 to 4.49
2.34 to 5.29
−0.65 to 1.01
−1.14 to 2.25
0.02 to 3.00
0.52 to 3.47

−0.94
−0.36
−1.53
−0.97
2.81
5.07
0.43
0.64
1.99
2.66

0.345
0.716
0.125
0.333
0.005
<0.001
0.667
0.519
0.046
0.008

2.44
0.75

−0.26 to −0.13
0.09 to 1.40

−6.03
2.24

<0.001
0.025

z

p

Model 2, Predicting depression symptoms: Wald χ 2 = 541.81, p < 0.001 (obs = 1,130)
b
Interindividual factors
Snoring
EPDS ≥10
PSASC ≥20
PFR ≥3
Intraindividual factors
Time
Prenatal vs Postpartum
ISI
Sleep duration
PSASC
PFR
PTQ

95% CI

0.88
1.86
0.13
0.75

−0.16 to 1.93
0.98 to 2.74
−0.69 to 0.95
−0.05 to 1.54

−0.09
0.70
0.12
0.03
0.09
0.33
0.17

−0.15 to −0.04
0.15 to 1.26
0.07 to 0.16
−0.13 to 0.18
0.04 to 0.13
0.16 to 0.51
0.14 to 0.19

1.66
4.15
0.30
1.84

0.096
<0.001
0.761
0.066

−3.54
2.48
5.10
0.36
3.68
3.68
14.44

<0.001
0.013
<0.001
0.717
<0.001
<0.001
<0.001

Model 3, Predicting positive depression status: Wald χ 2 = 128.83, p < 0.001 (obs = 1,130)

Interindividual factors
Snoring
EPDS ≥10
PSASC ≥20
PFR ≥3
Intraindividual factors
Time
Prenatal vs Postpartum
ISI ≥10
PSASC ≥20
PFR ≥3
PTQ ≥10

OR

95% CI

z

p

0.84
13.85
1.12
2.04

—
4.27 to 44.93
—
—

−0.26
4.38
0.20
1.35

0.791
<0.001
0.844
0.178

0.91
1.68
2.36
3.05
2.05
7.48

0.83 to 0.99
—
1.28 to 4.35
1.60 to 5.79
1.11 to 3.79
3.90 to 14.32

−2.04
1.12
2.76
4.03
2.30
6.06

0.041
0.264
0.006
<0.001
0.021
<0.001

The Wald χ 2 statistic reflects the difference between the tested model and a null model with no predictors. Thus, a significant χ 2 is desirable as it indicates a model
that accounts for significant variance in the outcome. obs = observations; b = unstandardized parameter estimate; SE = standard error; 95% CI = 95% confidence
interval; z = z-statistic; p = significance value. Interindividual factors were recorded at the study baseline, and significant effects represent between-subject differences. Intraindividual factors were recorded weekly across peripartum, and significant effects represent within-subject associations. Age represents age in years
reported at baseline. Poverty was operationalized as less than $20,000 of annual household income. BMI = body mass index; BMI ≥ 35 represents obesity class II.
Snoring was recorded at study entry (Yes = 1, No = 0). EPDS = Edinburgh postnatal depression scale, scores 10 and higher indicate probable minor or major depression. ISI = Insomnia Severity Index, scores 10 and higher indicate clinically significant symptoms. Short sleep operationalized as averaging ≤6 h per night over the
prior month. Time represents study week. Prenatal vs Postpartum coded as prenatal = 0 and postpartum = 1. ISI as an intraindividual factor represents insomnia
symptom severity over the prior week. Sleep duration as an intraindividual factor represents the average nightly sleep duration over the prior week. PSASC as an
interindividual factor represents trait nocturnal cognitive arousal; scores of 20 and higher indicate high nocturnal cognitive arousal. PSASC as an intraindividual
factor represents nocturnal cognitive arousal over the prior week. PFR represents nocturnal perinatal-focused rumination; scores of 3 and higher indicate high
perinatal-focused rumination. PFR as an intraindividual factor represents nocturnal perinatal-focused rumination over the prior week. PTQ represents perseverative
thinking over the prior week; scores of 10 and higher indicate elevated perseverative thinking levels.
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Interindividual factors
Prior miscarriage
Age
Poverty
BMI ≥35
Snoring
EPDS ≥10
ISI ≥10
Short sleep (≤6 h/night)
PSASC ≥20
PFR ≥3
Intraindividual factors
Time
Prenatal vs Postpartum
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Table 3. Linear mixed models to evaluate nocturnal cognitive arousal as a mediator of insomnia and depression
Tau Path, Insomnia predicting depression: Wald χ 2 = 116.58, p < 0.001 (obs = 987)
95% CI

b

2.42
3.29
1.28
1.55
−0.09
0.15
0.07
0.13

0.52 to 4.32
1.71 to 4.87
−0.21 to 2.77
0.11 to 3.00
−0.16 to −0.01
−0.49 to 0.79
0.02 to 0.11
0.06 to 0.19

p

2.50
4.08
1.69
2.11

0.012
<0.001
0.092
0.035

−2.36
0.46
2.65
3.88

0.018
0.645
0.008
<0.001

z

p

Alpha Path, Insomnia predicting nocturnal cognitive arousal: Wald χ 2 = 244.39, p < 0.001 (obs = 1,051)
95% CI

b
Interindividual factors
Snoring
EPDS ≥10
PSASC ≥20
PFR ≥3
Intraindividual factors
Time
Prenatal vs Postpartum
ISI, lagged 1 week
PSASC, lagged 1 week

3.65
1.89
2.29
1.19
−0.11
−0.56
0.08
0.26

1.28 to 6.02
−0.09 to 3.87
0.43 to 4.15
−0.62 to 3.00
−0.20 to −0.03
−1.36 to 0.24
0.02 to 0.15
0.19 to 0.33

3.02
1.87
2.41
1.29

0.003
0.061
0.016
0.198

−2.67
−1.37
2.58
7.68

0.008
0.171
0.010
<0.001

z

p

Beta Path, Nocturnal cognitive arousal predicting depression: Wald χ 2 = 208.62, p < 0.001 (obs = 978).
95% CI

b
Interindividual factors
Snoring
EPDS ≥10
PSASC ≥20
PFR ≥3
Intraindividual factors
Time
Prenatal vs Postpartum
ISI, lagged 2 weeks
EPDS, lagged 2 weeks
PSASC, lagged 1 week

1.80
2.69
.82
1.17

0.19 to 3.41
1.34 to 4.03
−0.44 to 2.08
−0.06 to 2.39

2.19
3.91
1.27
1.86

0.029
<0.001
0.203
0.063

−0.05
0.24
0.04
0.10
0.20

−0.13 to 0.02
−0.40 to 0.87
−0.01 to 0.09
0.03 to 0.16
0.15 to 0.25

−1.47
0.73
1.59
2.90
8.45

0.140
0.463
0.112
0.004
<0.001

The Wald χ2 statistic reflects the difference between the tested model and a null model with no predictors. Thus, a significant χ2 is desirable as it indicates a model that
accounts for significant variance in the outcome. obs = observations. Tau path represents the direct path from insomnia to future depression. Alpha path represents part of
the indirect (mediated) effect wherein insomnia influences future cognitive arousal. Beta path represents the other part of the indirect (mediated) effect wherein cognitive
arousal influences future depression. b = unstandardized parameter estimate; SE = standard error; 95% CI = 95% confidence interval; z = z-statistic; p = significance value.
Interindividual factors were recorded at the study baseline, and significant effects represent between-subject differences. Intraindividual factors were recorded weekly
across peripartum, and significant effects represent within-subject associations. Lagged 2 weeks indicates Xit−2. Lagged 1 week indicates Xit−1. Snoring was recorded at study
entry (Yes = 1, No = 0). EPDS ≥10 indicates clinically significant depression. PSASC ≥20 indicates high nocturnal cognitive arousal. PFR ≥3 indicates high nocturnal perinatalfocused rumination. Time represents study week. Prenatal vs Postpartum coded as prenatal = 0 and postpartum =1. ISI (insomnia severity index) as an intraindividual factor
represents insomnia symptom severity over the prior week. PSASC as an intraindividual factor represents nocturnal cognitive arousal over the prior week.

overlap with zero, mediation was supported. Nocturnal cognitive arousal was estimated to mediate 23% (αβ/τ = 0.016/0.07) to
43% (τ−τ′/τ = [0.07−0.04]/0.07) of the effect of insomnia on future
depression (Figure 2).

Does insomnia mediate the effects of nocturnal
cognitive arousal on depression?
We then conducted a series of linear mixed models to test
whether insomnia mediated prospective effects of nocturnal
cognitive arousal on depression (see Table 4 for full results).

τ path (direct effect)
We regressed depressive symptoms onto nocturnal cognitive
arousal (lagged by 2 weeks), while controlling for past depressive
symptoms and covariates (Table 4). Results supported a direct
effect of nocturnal cognitive arousal on depression 2 weeks later
(τ: b = 0.11, p < 0.001). Next, we examined the α and β paths of
the indirect effect.
α path
Nocturnal cognitive arousal predicted insomnia a week later (α:
b = 0.11, SE = 0.03, p < 0.001).
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Figure 2. Nocturnal cognitive arousal mediates the effect of insomnia on
depression.

PFR and insomnia.
When re-running these analyses with PFR, we observed a similar
pattern wherein insomnia or rumination alone increased depression risk, but depression risk was greatest when women endorsed insomnia and PFR simultaneously.

β path
Insomnia predicted depression a week later (β: b = 0.11, SE = 0.02,
p < 0.001). Nocturnal cognitive arousal remained a significant
predictor of depression (τ′: b = 0.09, p = 0.001).

Posthoc: Does depression predict cognitive arousal
or insomnia? Does bidirectionality exist between
daytime and nocturnal cognitive arousal?

αβ path (indirect effect)
Using the PRODCLIN method, the αβ path was estimated to be 0.013
(SE = 0.013, 97.5% CI = 0.003 to 0.024). Since the CI did not overlap
with zero, mediation was supported. Insomnia was estimated to
mediate 12% (αβ/τ = 0.013/0.11) to 18% (τ−τ′/τ = [0.11−0.09]/0.09) of
the effect of nocturnal cognitive arousal on depression (Figure 3)

Finally, we conducted a series of lagged linear mixed models,
which broadly showed that: (1) nocturnal cognitive arousal predicts future insomnia, but depression does not predict future
insomnia; (2) depression predicts both future nocturnal and
daytime cognitive arousal; and (3) evidence supports a bidirectional relationship between daytime perseverative thinking and
nighttime cognitive arousal. Please see Supplementary Materials
and Supplementary Table S5 for walkthrough and data.

Mediation models with perinatal rumination,
insomnia, and depression

Discussion

We repeated these analytic steps, replacing nocturnal cognitive arousal with nocturnal PFR (see Supplementary Materials
for step-by-step results). PFR was estimated to mediate 14%–
24% of the effect of insomnia on depression (Figure 4, Panel A;
Supplementary Table S1). In the other direction, results showed
that insomnia mediated approximately 13% of the effect of
baseline PFR on depression (Figure 4, Panel B; Supplementary
Table S2).

Mediation models with perseverative thinking,
insomnia, and depression
We repeated these steps a final time testing perseverative
thinking as the index for cognitive arousal (Supplementary
Tables S3 and S4). Although perseverative thinking reliably predicted future depression, no temporal associations were observed
between insomnia and perseverative thinking. Thus, mediation
models were not supported for perseverative thinking.

Do insomnia and cognitive arousal have
compounding effects on depression?
Our last hypothesis predicted that odds of depression would be
highest when women endorse clinically significant insomnia
and high cognitive arousal at the same time. We conducted
mixed effects logit models wherein depression status was regressed on three dummy coded variables per cut-points detailed
in the Measures section: (1) insomnia only, (2) high cognitive
arousal only, and (3) combined insomnia and high cognitive
arousal, plus covariates; see Supplementary Materials for stepby-step results.

In a sample of 70 women, insomnia and cognitive arousal
predicted future depression across late pregnancy and early
postpartum. Results showed that insomnia, nocturnal cognitive arousal, PFR, and perseverative thinking were each independently associated with perinatal depression. Critically,
bidirectionality was observed between insomnia and nocturnal
cognitive arousal, and this toxic cycle fueled perinatal depression. The combination of clinical insomnia and high cognitive
arousal corresponded to higher depression risk than insomnia
or high cognitive arousal alone. Notably, depression did not directly impact sleep, but did increase cognitive arousal during the
day and night. Overall, this study reveals a complex interplay
between insomnia and cognitive arousal in their influences
on perinatal depression. Cognitive arousal symptoms and insomnia may serve as key targets for the prevention and intervention of perinatal depression.

The role of cognitive arousal in perinatal insomnia
Before delving into the effects of insomnia and cognitive arousal
on depression, it is important to first characterize study results
that inform our understanding of how insomnia and cognitive
arousal relate to one another. Spielman’s 3-P model identifies
predisposing factors (i.e. vulnerabilities), precipitating events
(e.g. stress exposure), and perpetuating behaviors that lead to
the development and maintenance of insomnia [51]. Pregnancy
itself has been posited as a precipitating event for insomnia,
whereas the tendency for cognitive arousal and perseverative
thinking has been proposed as a predisposing factor [15]. That
is, while pregnancy is stressful for many women, it elicits especially strong responses in women prone to perseverate on
their own health, health of the fetus, finances, lifestyle changes,
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or high nocturnal cognitive arousal alone, but were highest
when experiencing insomnia and high nocturnal cognitive
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Table 4. Linear mixed models to evaluate insomnia as a mediator of nocturnal cognitive arousal and depression
Tau Path, Nocturnal cognitive arousal predicting depression: Wald χ 2 = 137.57, p < 0.001 (obs = 987)
95% CI

b

p

2.21
3.10
1.06
1.54

0.45 to 3.99
1.63 to 4.58
−0.33 to 2.46
0.20 to 2.88

2.45
4.13
1.49
2.25

0.014
<0.001
0.135
0.025

−0.07
0.18
0.11
0.10

−0.14 to 0.003
−0.46 to 0.82
0.06 to 0.16
0.03 to 0.17

−1.88
0.55
4.37
2.98

0.060
0.581
<0.001
.003

z

p

Alpha Path, Nocturnal cognitive arousal predicting insomnia: Wald χ 2 = 246.80, p < 0.001 (obs = 1,051).
95% CI

b
Interindividual factors
Snoring
EPDS ≥10
PSASC ≥20
PFR ≥3
Intraindividual factors
Time
Prenatal vs Postpartum
PSASC, lagged 1 week
ISI, lagged 1 week

2.92
0.78
0.88
2.33

0.82 to 5.02
−0.98 to 2.54
−0.77 to 2.54
0.73 to 3.93

2.72
0.87
1.05
2.86

0.007
0.383
0.295
0.004

−0.03
−0.11
0.11
0.36

−0.11 to 0.06
−0.91 to 0.68
0.05 to 0.17
0.29 to 0.42

−0.59
−0.28
3.37
10.91

0.554
0.778
0.001
<0.001

z

p

Beta Path, Insomnia predicting depression: Wald χ 2 = 155.82, p < .001 (obs = 978).
95% CI

b
Interindividual factors
Snoring
EPDS ≥10
PSASC ≥20
PFR ≥3
Intraindividual factors
Time
Prenatal vs Postpartum
PSASC, lagged 2 weeks
EPDS, lagged 2 weeks
ISI, lagged 1 week

2.01
2.89
0.98
1.18

0.28 to 3.75
1.44 to 4.33
−0.39 to 2.34
−0.14 to 2.50

2.27
3.91
1.40
1.75

0.023
<0.001
0.160
0.080

−0.07
0.14
0.09
0.09
0.11

−0.14 to 0.01
−0.50 to 0.78
0.04 to 0.14
0.03 to 0.16
0.06 to 0.15

−1.79
0.42
3.40
2.76
4.49

0.073
0.678
0.001
0.006
<0.001

The Wald χ 2 statistic reflects the difference between the tested model and a null model with no predictors. Thus, a significant χ 2 is desirable as it indicates a model
that accounts for significant variance in the outcome. obs = observations. Tau path represents the direct path from cognitive arousal to future depression. Alpha path
represents part of the indirect (mediated) effect wherein cognitive arousal influences future insomnia. Beta path represents the other part of the indirect (mediated)
effect wherein insomnia influences future depression. b = unstandardized parameter estimate; SE = standard error; 95% CI = 95% confidence interval; z = z-statistic;
p = significance value. Interindividual factors were recorded at the study baseline, and significant effects represent between-subject differences. Intraindividual factors were recorded weekly across peripartum, and significant effects represent within-subject associations. Lagged 2 weeks indicates Xit−2. Lagged 1 week indicates
Xit−1. Snoring was recorded at study entry (Yes = 1, No = 0). EPDS = Edinburgh postnatal depression scale, scores 10 and higher indicate probable minor or major
depression. Time represents study week. Prenatal vs Postpartum coded as prenatal = 0 and postpartum =1. EPDS as an intraindividual factor represents depression severity over the prior week. ISI (insomnia severity index) as an intraindividual factor represents insomnia symptom severity over the prior week. PSASC as an
intraindividual factor represents nocturnal cognitive arousal over the prior week.

Figure 3. Insomnia mediates the effect of nocturnal cognitive arousal on
depression.

and so on, during periods of high stress. This cognitive arousal
disrupts nightly sleep and contributes to the development of
insomnia. The effects of cognitive arousal on insomnia are especially well-documented [28, 52], with evidence showing that
cognitive arousal in the evening and night disrupts the onset
and maintenance of sleep [38, 39, 41, 53].
The effect of sleep disturbance on nighttime cognitive
arousal has received less attention, but even so, prospective data
suggest insomnia can trigger cognitive arousal [31]. Results from
the present study showing bidirectionality between insomnia
and cognitive arousal are significant for two key reasons: (1) The
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present study is the first to support bidirectionality between insomnia and cognitive arousal in a single sample, perinatal or
otherwise. (2) This study is the first to prospectively examine the
temporal associations between insomnia and cognitive arousal
in perinatal women. Our findings suggest that nocturnal cognitive arousal in peripartum interferes with falling and staying
asleep, which includes ruminating on concerns about pregnancy and fetal/infant health. In addition, our data suggest
that insomnia can trigger cognitive arousal. That is, when perinatal women lie in bed at night and struggle to sleep, nighttime
thoughts during this idleness may wander to concerns and
stressful thoughts from earlier in the day (supported by daytime cognitive arousal predicting nocturnal cognitive arousal).
Women who worry and ruminate on perinatal- and fetal/infantrelated distressing thoughts may be especially vulnerable to difficulty sleeping.
This bidirectionality between insomnia and cognitive
arousal may support nocturnal cognitive arousal as a perpetuating behavior in the 3-P model of insomnia. That is, increased
cognitive arousal at night in response to insomnia also serves to
perpetuate insomnia, thereby creating a toxic cycle. Notably, evidence from this study suggests that cognitive arousal does not
appear to have a stronger effect on insomnia than vice versa.
Future research is needed to further explore the development
and evolution of the insomnia–cognitive arousal cycle and to
better characterize the magnitude of effects in each direction.
Even so, currently available data, including from this study, are
clear that this cycle contributes to perinatal depression.

Does insomnia predict future perinatal depression?
Previous studies offered mixed results regarding the influence
of prenatal insomnia on postpartum depression [16, 21–23, 25].
Unlike prior investigations, our prospective analysis examined
temporal associations during pregnancy and postpartum at
the same time, rather than restrict analyses to testing effects
of prenatal sleep on postpartum depression. We observed that
higher levels of insomnia augured higher levels of depression,
irrespective of whether it was during pregnancy or postpartum.
Importantly, the influence of insomnia on future depression
was independent of the effects of prior depression, thereby
highlighting the robustness of this effect.
Past prospective studies have treated childbirth or the
postpartum period as a depression-triggering stressor and insomnia as a trait vulnerability: That is, women with insomnia
during pregnancy are more vulnerable to depression triggered
during postpartum. Our data offer a simpler characterization:

Poor sleep leads to mood disturbances at any point in peripartum.
Notably, depression did not increase insomnia, which is consistent with reports showing that the effect of sleep on mood
is more robust than in the opposite direction [11, 54–56]. Taken
together, these data suggest that insomnia may be a prodrome
to depression during peripartum. Yet, given the toxic cycle of insomnia and cognitive arousal outlined in the previous section,
cognitive arousal appears to play a critical role in the transaction from insomnia to depression. Thus, our inclusion of cognitive arousal within the perinatal insomnia–depression risk
relationship offers a more complex path from insomnia to depression in peripartum.

The depressogenic cycle of insomnia and
cognitive arousal
Directionality
Not only do insomnia and cognitive arousal feed into one another,
they mediate each other’s effect on depression. These data suggest that when perinatal women have difficulty sleeping, they
experience increases in depressive symptoms; however, this
may be partly because women spend much of their nocturnal
wakefulness perseverating on stressors and perinatal-related
concerns. We also observed that nocturnal cognitive arousal and
PFR disrupt sleep, and the resulting sleep disturbance partly accounted for the effect of cognitive arousal symptoms on depression. These results are consistent with prospective data from
perinatal and nonperinatal samples suggesting that the effects
of insomnia on depression are mediated by cognitive–emotional dysregulation [21, 30, 31], but also add to the literature by
showing that the effects of cognitive–emotional dysregulation
are also mediated by sleep disturbances. Importantly, we have
highlighted that cognitive arousal that occurs specifically at
night is most germane to the insomnia–depression risk relationship. Taken together, the present study depicted a vicious cycle
between insomnia and cognitive arousal that corrodes perinatal
mood and fuels depression.
Magnitude
Temporal associations simply show directionality of effects,
but do not necessarily lend easy interpretation of magnitude.
Important to emphasize here is that mild elevations in nocturnal cognitive arousal can produce transient insomnia, just as
a bad night of sleep can trigger ruminative thoughts while lying
in bed, which may persist after waking. Combined, a bad night
of sleep and a mild episode of ruminating at night will likely
negatively influence mood, but have no real lasting effects if the
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Figure 4. Panel A: Perinatal-focused rumination mediates the effect of insomnia on depression. Panel B: Insomnia mediates the effect of perinatal-focused rumination
on depression.
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Clinical implications for prevention and treatment
Women in prenatal care represent a critically important and highly
accessible patient population, given the regular appointments
throughout pregnancy and early postpartum. If insomnia and high
cognitive arousal are prodromes to perinatal depression, then early
detection of these symptoms may offer the opportunity for prevention or early intervention. To maximize treatment outcomes
for perinatal women receiving insomnia therapy, treatment may
need to be bolstered with greater emphasis on cognitive therapy,
rumination-focused cognitive behavioral therapy, mindfulnessbased, or emotion regulation interventions that successfully defuse cognitive arousal. Please refer to Supplementary Materials for
more clinical implications for prevention and treatment.

Limitations
These results should be interpreted in light of important methodological limitations. Chiefly, we collected data across just
4 months of the perinatal period. Following women for longer
periods, from early pregnancy to 12 months postpartum,
would provide a more thorough depiction of general trends in
symptom levels across peripartum and allow for exploring depression incidence and recurrence. Similarly, the sample size
is another limitation. While we had sufficient power to detect
intraindividual associations, we were likely underpowered for
detecting interindividual differences.
The timing between assessments is an important limitation
to consider. As discussed in the introduction, testing temporal
associations between prenatal sleep and postpartum depression

is not optimal. Along these lines, weekly assessments may not
be optimal either, even if more sensitive. Rather, these processes
likely occur both within a night (I ruminate tonight, so I have
difficulty falling asleep tonight) and day-to-day (I slept poorly
last night and ruminated in bed, so my mood is more negative
today), with compounding effects across longer periods when
cycles are sustained. Thus, although we showed that weekly assessments provide sufficient resolution to capture these temporal associations, we may have underestimated the magnitude
of these effects. Prospective observational studies with nightly/
daily assessments would likely better capture nuances and association strength.
Somewhat along these lines, our study findings should be
replicated in the laboratory to better understand causation,
characterize the timing of effects, and explore psychophysiological mechanisms that may facilitate these effects. Inducing
cognitive arousal or insomnia in the laboratory can demonstrate
how these experiences affect one another and even influence
mood upon waking the next day. Important to emphasize here,
however, is that multiple components of our model (but not
all) have been tested and supported in laboratory experiments
in nonperinatal samples (e.g. inducing cognitive–emotional
dysregulation triggers symptoms of insomnia [39, 53, 57] and
depression [58]).
Lastly, the measurement of PFR in the present study consisted of a single appended item to the PSASC. This has several
methodological limitations, which include limited variance inherent to single-item measures, an inability to separate shared
construct and methodological variance between PFR and PSASC
in the present study, and an exclusive focus on PFR that occurs
at night. Measurement of PFR deserves its own line of inquiry to
develop valid and reliable measures of this construct with emphasis on nocturnal and daytime phenomena. While we are reasonably confident in our study findings pertaining to PFR as they
are rather consistent with patterns observed when analyzing
more broadly focused nocturnal cognitive arousal in the present
study and prior research [5], these results should nevertheless
be considered tentative in nature and further explored in future
studies using more sophisticated measures.

Conclusions
Pregnancy and early postpartum are stressful periods. Perinatal
women endorse high levels of cognitive arousal, which includes
ruminating on pregnancy and fetal/infant health. Cognitive
arousal symptoms persist into the night and disrupt sleep.
Moreover, difficulty falling and staying asleep also provides
ample opportunity for nocturnal cognitive arousal. This cycle
between insomnia and cognitive arousal fuels perinatal depressive symptoms. Fortunately, insomnia and cognitive arousal
are modifiable with psychotherapy. Interventions to prevent
or maximally treat perinatal depression should improve sleep
quality while teaching patients adaptive strategies for coping
with stress and defusing negative repetitive thoughts, particularly while trying to sleep in bed at night.

Supplementary Material
Supplementary material is available at SLEEP online.
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cycle is not sustained. More simply stated, transient elevations
can be normal day-to-day experiences. The insomnia–cognitive
arousal cycle is not likely to produce clinical consequences until
these symptoms reach severe levels that are sustained over
time. When the cycle is weak (e.g. transient insomnia triggers
mild rumination for one night), the transaction has minimal to
no clinical significance. However, when insomnia and cognitive
arousal are severe and persist over time, then the cycle becomes
highly depressogenic. For a visual depiction of this cycle, please
refer to the conceptual model in Supplementary Figure S1.
Women were at a 20-fold increased odds for depression
when experiencing clinically significant insomnia symptoms
and high nocturnal cognitive arousal, relative to when they
reported sleeping well and low levels of arousal. The cycle
appears somewhat weakened when only sleep or cognitive–
emotional regulation is perturbed. Overall, when experiencing
only insomnia or only high cognitive arousal, women were
less likely to be depressed than when experiencing high levels
of both. Even so, experiencing just insomnia or high cognitive
arousal was associated with increased depression risk relative to when sleeping well and having low levels of cognitive
arousal. These data are consistent with evidence showing that
the prevalence of depression and suicidality is highest among
pregnant women with insomnia and high cognitive arousal
[5], and with prospective epidemiological data showing that
risk for incident major depression is highest among insomniacs with high cognitive arousal, relative to those with only
insomnia, only high cognitive arousal, or neither [35].

Kalmbach et al. |
14.

This study was funded by the American Academy of Sleep
Medicine (198-FP-18, PI: Kalmbach). P.C.’s effort was supported
by the National Heart, Lung, and Blood Institute (K23-HL13866,
PI: Cheng).

15.

16.

Disclosure Statement
Financial disclosure: P.C. has received research support from
Harmony Biosciences. C.L.D. has received research support
from Merck & Co. and has served on the speaker’s bureau
for Harmony Biosciences. No other financial or nonfinancial
interests exist.
Nonfinancial disclosure: The authors have no nonfinancial
disclosures to report.
Conflict of interest statement. None declared.

17.

18.

19.
20.

References
1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

Banti S, et al. From the third month of pregnancy to 1 year
postpartum. Prevalence, incidence, recurrence, and new
onset of depression. Results from the perinatal depressionresearch & screening unit study. Compr Psychiatry.
2011;52(4):343–351.
Woody CA, et al. A systematic review and meta-regression
of the prevalence and incidence of perinatal depression. J
Affect Disord. 2017;219:86–92.
Gavin NI, et al. Perinatal depression: a systematic review
of prevalence and incidence. Obstet Gynecol. 2005;106(5 Pt
1):1071–1083.
Field T. Postpartum depression effects on early interactions,
parenting, and safety practices: a review. Infant Behav Dev.
2010;33(1):1–6.
Kalmbach DA, et al. Depression and suicidal ideation in
pregnancy: exploring relationships with insomnia, short
sleep, and nocturnal rumination. Sleep Med. 2020;65:62–73.
Blackmore ER, et al. Previous prenatal loss as a predictor of perinatal depression and anxiety. Br J Psychiatry.
2011;198(5):373–378.
Blackmore ER, et al. Pregnancy-related anxiety: evidence
of distinct clinical significance from a prospective longitudinal study. J Affect Disord. 2016;197:251–258.
Dayan J, et al. Developmental model of depression applied
to prenatal depression: role of present and past life events,
past emotional disorders and pregnancy stress. PLoS One.
2010;5(9):e12942.
Viktorin A, et al. Heritability of perinatal depression
and genetic overlap with nonperinatal depression. Am J
Psychiatry. 2016;173(2):158–165.
DeJong H, et al. Rumination and postnatal depression: a
systematic review and a cognitive model. Behav Res Ther.
2016;82:38–49.
Ohayon MM, et al. Place of chronic insomnia in the
course of depressive and anxiety disorders. J Psychiatr Res.
2003;37(1):9–15.
Baglioni C, et al. Insomnia as a predictor of depression: a
meta-analytic evaluation of longitudinal epidemiological
studies. J Affect Disord. 2011;135(1–3):10–19.
Kalmbach DA, et al. Insomnia, short sleep, and snoring in
mid-to-late pregnancy: disparities related to poverty, race,
and obesity. Nat Sci Sleep. 2019;11:301–315.

21.

22.

23.

24.

25.

26.

27.
28.

29.

30.

31.

32.

33.

34.

D⊘rheim SK, et al. Insomnia and depressive symptoms in
late pregnancy: a population-based study. Behav Sleep Med.
2012;10(3):152–166.
Swanson LM, et al. Perinatal insomnia and mental
health: a review of recent literature. Curr Psychiatry Rep.
2020;22(12):1–9.
Sedov ID, Tomfohr-Madsen LM. Trajectories of insomnia symptoms and associations with mood and anxiety from early
pregnancy to the postpartum. Behav Sleep Med. 2020:1–12. doi:
10.1080/15402002.2020.1771339
Sivertsen B, et al. Trajectories of maternal sleep problems
before and after childbirth: a longitudinal populationbased study. BMC Pregnancy Childbirth. 2015;15:129.
Richter D, et al. Long-term effects of pregnancy and childbirth on sleep satisfaction and duration of first-time
and experienced mothers and fathers. Sleep. 2019;42(4).
doi:10.1093/sleep/zsz015
Dørheim SK, et al. Sleep and depression in postpartum
women: a population-based study. Sleep. 2009;32(7):847–855.
Emamian F, et al. Link between insomnia and perinatal depressive symptoms: a meta-analysis. J Sleep Res. 2019;28(6):e12858.
Marques M, et al. Is insomnia in late pregnancy a risk factor
for postpartum depression/depressive symptomatology?
Psychiatry Res. 2011;186(2–3):272–280.
Okun ML, et al. Changes in sleep quality, but not hormones
predict time to postpartum depression recurrence. J Affect
Disord. 2011;130(3):378–384.
Dørheim SK, et al. Can insomnia in pregnancy predict
postpartum depression? A longitudinal, population-based
study. PLoS One. 2014;9(4):e94674.
Osnes RS, et al. Mid-pregnancy insomnia and its association
with perinatal depressive symptoms: a prospective cohort
study. Behav Sleep Med. 2020:1–18. doi:10.1080/15402002.202
0.1743705
Okun ML, et al. Sleep complaints in late pregnancy and
the recurrence of postpartum depression. Behav Sleep Med.
2009;7(2):106–117.
Samtani S, et al. Assessing maladaptive repetitive thought
in clinical disorders: a critical review of existing measures.
Clin Psychol Rev. 2017;53:14–28.
Harvey AG, et al. Cognitive approaches to insomnia. Clin
Psychol Rev. 2005;25(5):593–611.
Pillai V, et al. Sleep and repetitive thought: the role of rumination and worry in sleep disturbance. Sleep and Affect.
London, UK: Elsevier; 2015: 201–225.
Drake CL, et al. Stress and sleep reactivity: a prospective investigation of the stress-diathesis model of insomnia. Sleep.
2014;37(8):1295–1304.
Batterham PJ, et al. Sleep disturbance, personality and the
onset of depression and anxiety: prospective cohort study.
Aust N Z J Psychiatry. 2012;46(11):1089–1098.
Danielsson NS, et al. Sleep disturbance and depressive
symptoms in adolescence: the role of catastrophic worry. J
Youth Adolesc. 2013;42(8):1223–1233.
Moberly NJ, et al. Ruminative self-focus and negative affect: an experience sampling study. J Abnorm Psychol.
2008;117(2):314–323.
Martini J, et al. A prospective-longitudinal study on the association of anxiety disorders prior to pregnancy and pregnancy- and child-related fears. J Anxiety Disord. 2016;40:58–66.
Swanson LM, et al. Relationships among depression, anxiety, and insomnia symptoms in perinatal women seeking
mental health treatment. J Womens Health (Larchmt).
2011;20(4):553–558.

Downloaded from https://academic.oup.com/sleep/advance-article/doi/10.1093/sleep/zsab028/6217388 by Henry Ford Hospital - Sladen Library user on 25 May 2021

Funding

13

14

|

SLEEPJ, 2021, Vol. XX, No. XX
46.

47.

48.

49.

50.

51.
52.

53.
54.

55.

56.

57.

58.

Nicassio PM, et al. The phenomenology of the pre-sleep
state: the development of the pre-sleep arousal scale. Behav
Res Ther. 1985;23(3):263–271.
Puzino K, et al. Am I (hyper)aroused or anxious? Clinical
significance of pre-sleep somatic arousal in young adults.
J Sleep Res. 2019;28(4):e12829.
Ehring T, et al. The Perseverative Thinking Questionnaire (PTQ):
validation of a content-independent measure of repetitive
negative thinking. J Behav Ther Exp Psychiatry. 2011;42(2):225–232.
Singer JD, et al. Applied Longitudinal Data Analysis: Modeling
Change and Event Occurrence. Oxford: Oxford University
Press; 2003.
Tofighi D, et al. RMediation: an R package for mediation analysis confidence intervals. Behav Res Methods.
2011;43(3):692–700.
Spielman AJ, et al. A behavioral perspective on insomnia
treatment. Psychiatr Clin North Am. 1987;10(4):541–553.
Harvey AG. Pre‐sleep cognitive activity: a comparison of
sleep‐onset insomniacs and good sleepers. Br J Clin Psychol.
2000;39(3):275–286.
Wuyts J, et al. The influence of pre-sleep cognitive arousal
on sleep onset processes. Int J Psychophysiol. 2012;83(1):8–15.
Kalmbach DA, et al. Effects of sleep, physical activity, and
shift work on daily mood: a prospective mobile monitoring
study of medical interns. J Gen Intern Med. 2018;33(6):914–920.
Jansson-Fröjmark M, et al. A bidirectional relationship
between anxiety and depression, and insomnia? A prospective study in the general population. J Psychosom Res.
2008;64(4):443–449.
Johnson EO, et al. The association of insomnia with anxiety
disorders and depression: exploration of the direction of
risk. J Psychiatr Res. 2006;40(8):700–708.
Chen IY, et al. Investigating psychological and physiological
responses to the Trier Social Stress Test in young adults
with insomnia. Sleep Med. 2017;40:11–22.
Nolen-Hoeksema S, et al. Rethinking rumination. Perspect
Psychol Sci. 2008;3(5):400–424.

Downloaded from https://academic.oup.com/sleep/advance-article/doi/10.1093/sleep/zsab028/6217388 by Henry Ford Hospital - Sladen Library user on 25 May 2021

35. Kalmbach DA, et al. Nocturnal insomnia symptoms
and stress-induced cognitive intrusions in risk for
depression: a 2-year prospective study. PLoS One.
2018;13(2):e0192088.
36. Evans J, et al. Cohort study of depressed mood during pregnancy and after childbirth. BMJ. 2001;323(7307):257–260.
37. Kalmbach DA, et al. Insomnia symptoms and short sleep
predict anxiety and worry in response to stress exposure:
a prospective cohort study of medical interns. Sleep Med.
2019;55:40–47.
38. Pillai V, et al. A seven day actigraphy-based study of rumination and sleep disturbance among young adults with depressive symptoms. J Psychosom Res. 2014;77(1):70–75.
39. Zoccola PM, et al. Rumination predicts longer sleep onset
latency after an acute psychosocial stressor. Psychosom Med.
2009;71(7):771–775.
40. Galbiati A, et al. Repetitive thought is associated with both
subjectively and objectively recorded polysomnographic
indices of disrupted sleep in insomnia disorder. Sleep Med.
2018;45:55–61.
41. Kalmbach DA, et al. Nocturnal cognitive arousal is
associated with objective sleep disturbance and in
dicators of physiologic hyperarousal in good sleepers
and individuals with insomnia disorder. Sleep Med.
2020;71:151–160.
42. Buysse DJ, et al. The Pittsburgh Sleep Quality Index: a new
instrument for psychiatric practice and research. Psychiatry
Res. 1989;28(2):193–213.
43. Cox JL, et al. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale.
Br J Psychiatry. 1987;150(6):782–786.
44. Bastien CH, et al. Validation of the Insomnia Severity Index
as an outcome measure for insomnia research. Sleep Med.
2001;2(4):297–307.
45. Morin CM, et al. The Insomnia Severity Index: psychometric
indicators to detect insomnia cases and evaluate treatment
response. Sleep. 2011;34(5):601–608.

